|
Name |
(4S)-3-Oxo-4-benzyl-3,4-dihydro-1H-pyrrolo[2,1-c][1,4]oxazine-6-carbaldehyde
|
| Molecular Formula | C15H13NO3 | |
| IUPAC Name* |
(4S)-4-benzyl-3-oxo-1,4-dihydropyrrolo[2,1-c][1,4]oxazine-6-carbaldehyde
|
|
| SMILES |
C1C2=CC=C(N2[C@H](C(=O)O1)CC3=CC=CC=C3)C=O
|
|
| InChI |
InChI=1S/C15H13NO3/c17-9-12-6-7-13-10-19-15(18)14(16(12)13)8-11-4-2-1-3-5-11/h1-7,9,14H,8,10H2/t14-/m0/s1
|
|
| InChIKey |
UMCJKAAHDXLKRZ-AWEZNQCLSA-N
|
|
| Synonyms |
(4S)-3-Oxo-4-benzyl-3,4-dihydro-1H-pyrrolo[2,1-c][1,4]oxazine-6-carbaldehyde; (S)-4-benzyl-3-oxo-3,4-dihydro-1H-pyrrolo[2,1-c] [1,4]oxazine-6-carbaldehyde
|
|
| CAS | NA | |
| PubChem CID | 122389043 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 255.27 | ALogp: | 2.1 |
| HBD: | 0 | HBA: | 3 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 48.3 | Aromatic Rings: | 3 |
| Heavy Atoms: | 19 | QED Weighted: | 0.626 |
| Caco-2 Permeability: | -4.661 | MDCK Permeability: | 0.00003120 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.007 |
| 30% Bioavailability (F30%): | 0.002 |
| Blood-Brain-Barrier Penetration (BBB): | 0.673 | Plasma Protein Binding (PPB): | 65.33% |
| Volume Distribution (VD): | 1.188 | Fu: | 35.77% |
| CYP1A2-inhibitor: | 0.914 | CYP1A2-substrate: | 0.085 |
| CYP2C19-inhibitor: | 0.948 | CYP2C19-substrate: | 0.158 |
| CYP2C9-inhibitor: | 0.764 | CYP2C9-substrate: | 0.547 |
| CYP2D6-inhibitor: | 0.062 | CYP2D6-substrate: | 0.356 |
| CYP3A4-inhibitor: | 0.197 | CYP3A4-substrate: | 0.615 |
| Clearance (CL): | 12.027 | Half-life (T1/2): | 0.673 |
| hERG Blockers: | 0.072 | Human Hepatotoxicity (H-HT): | 0.167 |
| Drug-inuced Liver Injury (DILI): | 0.922 | AMES Toxicity: | 0.018 |
| Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.677 |
| Skin Sensitization: | 0.14 | Carcinogencity: | 0.348 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.221 |
| Respiratory Toxicity: | 0.15 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003437 | ![]() |
0.523 | D0H6TP | ![]() |
0.320 | ||
| ENC002563 | ![]() |
0.420 | D02WCI | ![]() |
0.319 | ||
| ENC001970 | ![]() |
0.408 | D08FTG | ![]() |
0.316 | ||
| ENC004822 | ![]() |
0.408 | D05VLS | ![]() |
0.315 | ||
| ENC004861 | ![]() |
0.397 | D0B1FE | ![]() |
0.308 | ||
| ENC002940 | ![]() |
0.393 | D0G1VX | ![]() |
0.308 | ||
| ENC003272 | ![]() |
0.393 | D06BYV | ![]() |
0.306 | ||
| ENC003593 | ![]() |
0.382 | D0I0DL | ![]() |
0.305 | ||
| ENC001910 | ![]() |
0.380 | D05OIS | ![]() |
0.300 | ||
| ENC004648 | ![]() |
0.378 | D0QL3P | ![]() |
0.298 | ||